Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzalutamide in Advanced Granulosa Cell Ovarian Tumors
NCT03464201Phase 2Completed
- Sponsor
- Grupo Español de Tumores Huérfanos e Infrecuentes
- Start
- Apr 2018
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enzalutamide in ovarian granulosa cell tumor (OGCT), sponsored by Grupo Español de Tumores Huérfanos e Infrecuentes. Started Apr 2018; status: completed.
02
Drugs
enzalutamide
03
Conditions
ovarian granulosa cell tumor (OGCT)
Beyond the preview
Go deeper on NCT03464201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03464201.